MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-18-0061131
Bimal Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹7.32 Cr
▼ 39% YoY
Net profit · FY 2025
₹40.38 Lakh
Net margin 5.5%
EBITDA · FY 2025
₹64.33 Lakh
EBITDA margin 8.8%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹2 Cr
Issued & subscribed
Open charges
₹6.41 Cr
Satisfied ₹2.85 Cr
Company age
24 yrs
Est. 2002
Directors on board
2
As per MCA filings
About Bimal Pharma Private Limited
Data last updated:
Bimal Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 September 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51397MH2002PTC137273. Its GSTIN is 27AABCB9186E1ZJ (Maharashtra). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It is led by directors Jagdish Shamaldas Parikh and Kundan Jagdish Parikh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.32 Cr, a decline of 39% compared to the previous year. For the same year it recorded a net profit of ₹40.38 Lakh (net margin 5.5%) and EBITDA of ₹64.33 Lakh (EBITDA margin 8.8%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years and 6% over five years.
As per MCA filings, the company has open charges of ₹6.41 Cr and satisfied charges of ₹2.85 Cr on record. Court records list 8 cases involving the company, including 2 filed by the company and 6 filed against it.
Bimal Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0061131). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bimalpha.com.
Company details
CIN U51397MH2002PTC137273
Registration Number 137273
Incorporation Date 19 September 2002
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-18-0061131
Recognitions & Rankings of Bimal Pharma
Contact details
Bimal Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is bimalpha.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressFlat No. Ic – 10 Indraprasth Chs Ltd Jitendra Road Opp. Ashoka Hospital Mal, Ad (East), Mumbai, Maharashtra, India – 400097
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Bimal Pharma Private Limited, buy the company report.
Comprehensive company report
Bimal Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Bimal Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Bimal Pharma Private Limited, buy the company report.
Financials of Bimal Pharma Private Limited
FY 2025 filings availableBimal Pharma Private Limited reported revenue of ₹7.32 Cr (down 39% YoY) for FY 2025.
Revenue · FY 2025
₹7.32 Cr ▼ 39%
Net profit · FY 2025
₹40.38 Lakh margin 5.5%
EBITDA · FY 2025
₹64.33 Lakh margin 8.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 39%
3 years · compounded
▼ 7%
5 years · compounded
▼ 6%
EBITDA CAGR growth
1 year
▼ 35%
3 years · compounded
▲ 7%
Revenue has declined at a compounded annual rate (CAGR) of 6% over five years, including a 39% fall in the latest year. EBITDA fell 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹64.33 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹40.38 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.8% | ||||
| Net Profit Margin | 5.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bimal Pharma Private Limited, buy the company report.
Board of directors of Bimal Pharma Private Limited
Bimal Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jagdish Shamaldas Parikh | Director | 19 Sep 2002 | 24 Years 1 Months | Current |
| Kundan Jagdish Parikh | Director | 19 Sep 2002 | 24 Years 1 Months | Current |
Peer comparison
Bimal Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Auraleafs Labs Private Limited | ₹7.33 Cr (FY 2021) | 81.0% | Hyderabad, Telangana, India | |||
| Bimal Pharma Private Limitedthis company | ₹7.32 Cr (FY 2025) | ₹40.38 Lakh | 5.5% | -39.0% | Mumbai, Maharashtra, India | |
| Choroid Laboratories Private Limited | ₹7.29 Cr (FY 2025) | 0.0% | Kurukshetra, Haryana, India | |||
| Chethana Formulations Private Limited | ₹7.27 Cr (FY 2025) | -21.0% | Malappuram, Kerala, India |
To see the full peer comparison of Bimal Pharma Private Limited, buy the company report.
Auditor
Bimal Pharma Private Limited is audited by Vayeda and Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Vayeda and Associates | FY 2024 | 154034W |
Shareholding
The shareholding of Bimal Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Bimal Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹6.41 Cr
Satisfied charges
₹2.85 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Jan 2005 | 90149037 | Others | ₹3.91 Cr | Open | |
| 09 Sep 2004 | 90148862 | Sbi Factors and Commercial Services Ltd. | ₹2.5 Cr | Open | |
| 30 Dec 2003 | 90148523 | The Saraswat Co - Op. Bank Ltd. | ₹15 Lakh | Satisfied | |
| 10 Feb 2003 | 90148167 | The Saraswat Co - Op. Bank Ltd. | ₹40 Lakh | Satisfied | |
| 07 Feb 2003 | 90148163 | The Saraswat Co - Op. Bank Ltd. | ₹50 Lakh | Satisfied |
To see the full charge records of Bimal Pharma Private Limited, buy the company report.
Total charge records: 6 View all charges
Legal cases
Bimal Pharma Private Limited has 8 court cases on record: 2 filed by Bimal Pharma, 6 filed against it. All cases are disposed.
Total cases
8
Filed by the company
2
Filed against the company
6
Disposed
8
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 6 | 0 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons cases SS) | Filed against the company by Reliance Capital Ltd. | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons cases SS) | Filed against the company by HDFC Bank Ltd | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (S S) | Filed against the company by Reliance Capital Ltd | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Private cases SS) | Filed against the company by Excel Industries Limited | Disposed |
| District court, Ahmedabad, Gujarat | Court case (SMST R) | Filed by the company against Vipul R. Shah, Director of M/S. Hindustan Industries and 1 other | Disposed |
To see the full case history of Bimal Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bimal Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bimal Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCB9186E1ZJ | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Bimal Pharma Private Limited, buy the company report.
Recent activity
Bimal Pharma Private Limited has 2 board changes on record since 2002: 2 appointments. The latest: Jagdish Shamaldas Parikh was appointed as Director on 19 Sep 2002.
AGM
Bimal Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Bimal Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Others of Rs. 3.91 Cr registered on 14 Jan 2005 with Charge ID 90149037 was modified on 31 Aug 2021.
Charges
A charge registered on 30 Dec 2003 via Charge ID 90148523 with The Saraswat Co - Op. Bank Ltd. was fully satisfied on 22 Apr 2019.
Charges
A charge registered on 10 Feb 2003 via Charge ID 90148167 with The Saraswat Co - Op. Bank Ltd. was fully satisfied on 22 Apr 2019.
Charges
A charge registered on 07 Feb 2003 via Charge ID 90148163 with The Saraswat Co - Op. Bank Ltd. was fully satisfied on 22 Apr 2019.
Charges
A charge registered on 17 Jan 2003 via Charge ID 90148141 with The Saraswat Co - Op. Bank Ltd. was fully satisfied on 22 Apr 2019.
Charges
A charge with Others amounted to Rs. 3.91 Cr with Charge ID 90149037 was registered on 14 Jan 2005.
Charges
A charge with The Saraswat Co - Op. Bank Ltd. of Rs. 0.40 Cr registered on 10 Feb 2003 with Charge ID 90148167 was modified on 02 Dec 2004.
Charges
A charge with Sbi Factors And Commercial Services Ltd. amounted to Rs. 2.50 Cr with Charge ID 90148862 was registered on 09 Sep 2004.
Charges
A charge with The Saraswat Co - Op. Bank Ltd. amounted to Rs. 0.15 Cr with Charge ID 90148523 was registered on 30 Dec 2003.
Charges
A charge with The Saraswat Co - Op. Bank Ltd. amounted to Rs. 0.40 Cr with Charge ID 90148167 was registered on 10 Feb 2003.
5 earlier events are in the company report.
Frequently asked questions
Bimal Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 September 2002 (24+ years old) and is registered under CIN U51397MH2002PTC137273.
Bimal Pharma has 2 current directors:
- Jagdish Shamaldas Parikh - Director
- Kundan Jagdish Parikh - Director
The latest financial statements of Bimal Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Bimal Pharma is 27AABCB9186E1ZJ, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Bimal Pharma is U51397MH2002PTC137273. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bimal Pharma has 8 court cases on record: 2 filed by the company and 6 filed against it.
Bimal Pharma was incorporated on 19 September 2002, making it 24+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Bimal Pharma by revenue are Auraleafs Labs Private Limited, Choroid Laboratories Private Limited, Chethana Formulations Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Jagdish Shamaldas Parikh was appointed as Director on 19 Sep 2002. Kundan Jagdish Parikh was appointed as Director on 19 Sep 2002.
Yes, Bimal Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-MH-18-0061131).
Bimal Pharma can be reached through the website bimalpha.com. Its registered office is in Mumbai, Maharashtra, India.